U.S. to boost baby formula imports to ease nationwide shortage after Abbott Nutrition recall

U.S. to boost baby formula imports to ease nationwide shortage after Abbott Nutrition recall


Baby formula is offered for sale at a big box store on January 13, 2022 in Chicago, Illinois.

Scott Olson | Getty Images

The U.S. will increase baby formula imports as part of an effort to ease a nationwide shortage, senior Biden administration officials said on Thursday.

The scarcity of formula was triggered in part by the closure of a Michigan manufacturing plant after two infants who consumed its products caught bacterial infections and died.

The Food and Drug Administration will announce specific actions to boost formula imports in the coming days, the officials said. The U.S. produces 98% of the infant formula its consumes. Chile, Ireland, Mexico and the Netherlands are potential sources for additional imports, according to the officials.

Abbott Nutrition, the nation’s largest baby formula manufacturer, issued a recall in February for several powered formulas. The move came after four infants who consumed products from its Sturgis, Michigan, plant were hospitalized with infections from the bacteria Cronobacter sakazakii. Two of the infants died.

Abbott closed the Sturgis plant and recalled its Similac PM 60/40, Similac, Alimentum and EleCare powered formulas manufactured at the Michigan facility. The company said Cronobacter sakazakii was found at the plant, but not in areas where it makes product. All finished product tested came back negative for the bacteria, according to Abbott.

The FDA and the Centers for Disease Control and Prevention have instructed parents to check Abbott’s website to find out if they have a product under recall. The FDA is advising consumers not to use recalled Similac, Alimentum or EleCare powdered infant formulas.

The plant closure and recall have left parents scrambling to find baby formula.

During the first week of May, 43% of baby formula supplies were out of stock at stores across the U.S., according to Datasembly, a company that tracks retail data. Abbott said it can restart the Sturgis plant within two weeks if the FDA signs off, but it will take up to eight weeks for products to make it to stores.

President Joe Biden met earlier on Thursday with Walmart, Target, Reckitt and Gerber to discuss ways to ease the shortage. Biden has asked the Federal Trade Commission to use its power to monitor reports of price gouging amid the shortage, and the Justice Department is working with state attorneys general to deal with predatory behavior by retailors, the administration officials said.

The CDC has not identified any additional cases of infection related to the powered formula and has closed its investigation. It has called for state health departments to report any infant Cronobacter infections they find.

Cronobacter can cause blood infections or make the linings around the brain and spinal cord swell, according to the CDC. Symptoms include a fever, poor feeding, excessive crying, very low energy and seizures.

CNBC Health & Science

Read CNBC’s latest global coverage of the Covid pandemic:



Source

Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
Health

Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says

The CEO of Novartis said Wednesday that the Swiss pharmaceutical giant does not plan to enter into the “frenzy” of weight loss drugs, preferring instead to focus on areas where it can build a “unique position.” Speaking to CNBC, Vas Narasimhan said that the company was researching treatments that deal with the secondary effects of […]

Read More
23andMe CEO Anne Wojcicki ‘surprised and disappointed’ by board resignations: Read the memo
Health

23andMe CEO Anne Wojcicki ‘surprised and disappointed’ by board resignations: Read the memo

Anne Wojcicki, co-founder and chief executive officer of 23andme Inc., during the South by Southwest (SXSW) festival in Austin, Texas, US, on Friday, March 10, 2023.  Jordan Vonderhaar | Bloomberg | Getty Images All seven independent directors of 23andMe resigned from the company’s board Tuesday, a move that CEO Anne Wojcicki said left her “surprised […]

Read More
Healthy Returns: How competitive can Roche be in the weight loss drug market?
Health

Healthy Returns: How competitive can Roche be in the weight loss drug market?

Headquarters of Roche, multinational pharmaceutical industry on December 27, 2021 in Madrid, Spain.  Cristina Arias | Cover | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Good afternoon! Roche is one of several drugmakers […]

Read More